(lp0
S'aTyr Pharma Announces Fourth Quarter and Year-End 2016 Operating Results PR Newswire  - Mar 16, 2017 SAN DIEGO, March 16, 2017 /PRNewswire/ -- aTyr Pharma, Inc. , a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced operating results&nbsp;...Atyr Pharma reports 4Q loss - Yahoo FinanceHow has aTyr Pharma, Inc. performed recently? - The Daily Leicester'
p1
aS"aTyr Pharma to Present at Cowen and Company 37th Annual Health Care Conference PR Newswire  - Mar 1, 2017 SAN DIEGO, March 1, 2017 /PRNewswire/ -- aTyr Pharma, Inc. , a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced the Company's&nbsp;...Active Volume Stock: aTyr Pharma Inc.  - HugoPressAnalysts showing optimistic trends for: aTyr Pharma Inc.  - News Oracle"
p2
aS'aTyr Pharma Announces Issuance of US Patent That Extends Patent Protection of ... PR Newswire  - Mar 15, 2017 SAN DIEGO, March 15, 2017 /PRNewswire/ -- aTyr Pharma, Inc. , a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced the issuance of US&nbsp;...'
p3
aS'aTyr Pharma Appoints Industry Veteran in Novel Biology Biologics, David J ... PR Newswire  - Sep 21, 2016 SAN DIEGO, Sept. 21, 2016 /PRNewswire/ -- aTyr Pharma, Inc. , today announced that David J. King, PhD, has joined the company as Senior Vice President, Research.'
p4
aS"aTyr Pharma Presents Additional Data for Resolaris Phase 1b/2 Trial in Adult ... PR Newswire  - Oct 6, 2016 SAN DIEGO, Oct. 6, 2016 /PRNewswire/ -- aTyr Pharma, Inc. , today announced that additional clinical data from aTyr's Phase 1b/2 Trial  in adult patients with FSHD were presented at the 21st International Congress of the World Muscle&nbsp;..."
p5
aS'aTyr Pharma Announces Presentation at the 21st International Annual Congress ... PR Newswire  - Sep 29, 2016 SAN DIEGO, Sept. 29, 2016 /PRNewswire/ -- aTyr Pharma, Inc. , a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced participation in the&nbsp;...Gershman of aTyr Pharma to Speak on Muscular Dystrophy  - Investopedia'
p6
aS'aTyr Pharma Announces Second Quarter 2016 Operating Results PR Newswire  - Aug 10, 2016 SAN DIEGO, Aug. 10, 2016 /PRNewswire/ -- aTyr Pharma, Inc. , a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced operating results for&nbsp;...'
p7
aS'aTyr Pharma Inc. LIFE  Wall Street Journal - Feb 12, 2011 News aTyr Pharma Inc.LIFE. Significant News Only. 03/16/17; Press Release. aTyr Pharma Announces Fourth Quarter and Year-End 2016 Operating Results.'
p8
aS'aTyr Pharma to Present at the BMO Prescriptions for Success Healthcare Conference PR Newswire  - Dec 9, 2016 SAN DIEGO, Dec. 9, 2016 /PRNewswire/ -- aTyr Pharma, Inc. , a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced that senior&nbsp;...'
p9
aS'aTyr Pharma Enters into $20 Million Credit Facility PR Newswire  - Nov 21, 2016 SAN DIEGO, Nov. 21, 2016 /PRNewswire/ -- aTyr Pharma, Inc. , a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced it has entered into a&nbsp;...'
p10
a.